<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
        {font-family:"Cambria Math";
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0in;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:#0563C1;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:#954F72;
        text-decoration:underline;}
span.EmailStyle17
        {mso-style-type:personal-compose;
        font-family:"Calibri",sans-serif;
        color:windowtext;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-family:"Calibri",sans-serif;}
@page WordSection1
        {size:8.5in 11.0in;
        margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
        {page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal" style="margin-bottom:12.0pt"><o:p> </o:p></p>
<p class="MsoNormal"><b>Terms of Reference (Original Deadline in Board Resolution - March 30, 2017)</b><o:p></o:p></p>
<p class="MsoNormal">This original deadline was not going to be met since the Team appointments were completed late and the Team met for the first time on 15 March 2017. On 22 March 2017 the SSR2 Team noted in their
<a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__community.icann.org_display_SSR_SSR2-2BMeeting-2B-25233-2B-2D-2B-2B22-2BMarch-2B2017-2B-40-2B19-253A00-2BUTC-3Fpreview-3D_64076719_64077638_Final-2520Draft-2520SSR2-2520RT-252022March2017.pdf&d=DwMFaQ&c=5VD0RTtNlTh3ycd41b3MUw&r=MWVuq3jZIw5gwhGdDf-HWNL4CEWIsdUnt9gOgplCArM&m=kgYZR7j9jNxZY5G6iGkX8Nf9bEQAwzw58SYTlqkq5XU&s=UG6MhjZU7VdBy4YWvNZ0R2dEh8G4LVnPX8X8Lz8Q0O4&e=" target="_blank">
Slides (p.6-7)</a> that the Board needed to be emailed about the deadline. In the email archive, Kaveh (<a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__mm.icann.org_pipermail_ssr2-2Dreview_2017-2DMarch_000138.html&d=DwMFaQ&c=5VD0RTtNlTh3ycd41b3MUw&r=MWVuq3jZIw5gwhGdDf-HWNL4CEWIsdUnt9gOgplCArM&m=kgYZR7j9jNxZY5G6iGkX8Nf9bEQAwzw58SYTlqkq5XU&s=WIsZ3IJ2eP6qmA4NGpd0TmXjWu1dnepogMjd76pjyKE&e=" target="_blank">message
 on 28 March</a>) said that the Board has been informed and that he will wait for feedback; none was forthcoming. <o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><img border="0" width="544" height="220" style="width:5.6666in;height:2.2916in" id="Picture_x0020_1" src="cid:image001.png@01D43AE3.F8C738E0" alt="Inline images 6"><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b>Terms of Reference- SSR2 Meeting - 2 May 2017 </b><o:p></o:p></p>
<p class="MsoNormal">The Terms of Reference v.3 was discussed. In the meeting transcript Emily (co-chair) suggested that the Team had ample discussion about, and work on, ToR and that everyone was pretty happy (p. 7). Eric (co-chair) questioned whether any
 members were still concerned, but then when he asked, some of the potential objectors he named said they were happy with Emily's proposal for adoption.<o:p></o:p></p>
<p class="MsoNormal"><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__community.icann.org_display_SSR_SSR2-2BMeeting-2B-25239-2B-2D-2B02-2BMay-2B2017-2B-40-2B14-253A00-2BUTC-3Fpreview-3D_64080946_64949081_SSR2-5FReview-5FTeam-5F-5FMeeting-5F-5F9-5F-5F02-5FMAY-5F2017.pdf&d=DwMFaQ&c=5VD0RTtNlTh3ycd41b3MUw&r=MWVuq3jZIw5gwhGdDf-HWNL4CEWIsdUnt9gOgplCArM&m=kgYZR7j9jNxZY5G6iGkX8Nf9bEQAwzw58SYTlqkq5XU&s=c70F_wTkIeTqdQlWzRyDfOlOxGXONrJkBiuOXO3b96g&e=" target="_blank"><span style="color:blue"><br>
</span></a><o:p></o:p></p>
<p class="MsoNormal"><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__community.icann.org_display_SSR_SSR2-2BMeeting-2B-25239-2B-2D-2B02-2BMay-2B2017-2B-40-2B14-253A00-2BUTC-3Fpreview-3D_64080946_64949081_SSR2-5FReview-5FTeam-5F-5FMeeting-5F-5F9-5F-5F02-5FMAY-5F2017.pdf&d=DwMFaQ&c=5VD0RTtNlTh3ycd41b3MUw&r=MWVuq3jZIw5gwhGdDf-HWNL4CEWIsdUnt9gOgplCArM&m=kgYZR7j9jNxZY5G6iGkX8Nf9bEQAwzw58SYTlqkq5XU&s=c70F_wTkIeTqdQlWzRyDfOlOxGXONrJkBiuOXO3b96g&e=" target="_blank">Meeting
 transcript (pg. 7-8)</a><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><img border="0" width="544" height="526" style="width:5.6666in;height:5.4791in" id="Picture_x0020_2" src="cid:image002.png@01D43AE3.F8C738E0" alt="Inline images 1"><br>
<img border="0" width="552" height="275" style="width:5.75in;height:2.8645in" id="Picture_x0020_3" src="cid:image003.png@01D43AE3.F8C738E0" alt="Inline images 2"><o:p></o:p></p>
<p class="MsoNormal"><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__community.icann.org_display_SSR_SSR2-2BMeeting-2B-25239-2B-2D-2B02-2BMay-2B2017-2B-40-2B14-253A00-2BUTC-3Fpreview-3D_64080946_64947719_CHAT-2520Transcript-2520SSR2-2520Review-2520Team-5F-2520Meeting-2520-25239-5F-2520-252002-2520MAY-252017.docx&d=DwMFaQ&c=5VD0RTtNlTh3ycd41b3MUw&r=MWVuq3jZIw5gwhGdDf-HWNL4CEWIsdUnt9gOgplCArM&m=kgYZR7j9jNxZY5G6iGkX8Nf9bEQAwzw58SYTlqkq5XU&s=OpIFLM3knA-BPOIO7rb741QZnUF04vfS9eHUfDoDbCw&e=" target="_blank">Chat
 Transcript, meeting 9 (p.3) </a><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><img border="0" width="544" height="92" style="width:5.6666in;height:.9583in" id="Picture_x0020_4" src="cid:image004.png@01D43AE3.F8C738E0" alt="Inline images 3"><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">After addressing the minor wording and definitional issues suggested by members of the SSR2 Team, a 24 hour "final comments via email" period was suggested before the final draft was to be uploaded and sent to the Board. These changes were
 made and uploaded as v. 4 of the TOR and sent to the mailing list on May 3rd. (See <a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__mm.icann.org_pipermail_ssr2-2Dreview_2017-2DMay_000240.html&d=DwMFaQ&c=5VD0RTtNlTh3ycd41b3MUw&r=MWVuq3jZIw5gwhGdDf-HWNL4CEWIsdUnt9gOgplCArM&m=kgYZR7j9jNxZY5G6iGkX8Nf9bEQAwzw58SYTlqkq5XU&s=F7QhTKhygmxenQ4cN_JDvji4xZ2Vvo9myDHU_xRWlSI&e=" target="_blank">Email
 Log, Wednesday May 3</a>)  <o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><img border="0" width="544" height="399" style="width:5.6666in;height:4.1562in" id="Picture_x0020_5" src="cid:image005.png@01D43AE3.F8C738E0" alt="Inline images 4"><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__mm.icann.org_pipermail_ssr2-2Dreview_2017-2DMay_date.html&d=DwMFaQ&c=5VD0RTtNlTh3ycd41b3MUw&r=MWVuq3jZIw5gwhGdDf-HWNL4CEWIsdUnt9gOgplCArM&m=kgYZR7j9jNxZY5G6iGkX8Nf9bEQAwzw58SYTlqkq5XU&s=DbFbXMTLgALJspYrhzhfWKVMTGOsWTFgQPsJqJ66l-E&e=" target="_blank">No
 objections were raised in the email archive of the SSR2 team</a> in that 24 hour period, nor later. Thus, consensus was reached and
<a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__community.icann.org_display_SSR_Terms-2Bof-2BReference-3Fpreview-3D_64076120_64948210_SSR2-2DTermsofReference-2DCLEAN-2520v4.0-2520ET.docx&d=DwMFaQ&c=5VD0RTtNlTh3ycd41b3MUw&r=MWVuq3jZIw5gwhGdDf-HWNL4CEWIsdUnt9gOgplCArM&m=kgYZR7j9jNxZY5G6iGkX8Nf9bEQAwzw58SYTlqkq5XU&s=2U_AP1uQvqn4GYIh-AQNhiyhUFkxnTMKK416yZrU1tQ&e=" target="_blank">
Version 4 of the Terms of Reference</a> was adopted on 4 May and sent to the Board (<a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__mm.icann.org_pipermail_ssr2-2Dreview_2017-2DMay_000262.html&d=DwMFaQ&c=5VD0RTtNlTh3ycd41b3MUw&r=MWVuq3jZIw5gwhGdDf-HWNL4CEWIsdUnt9gOgplCArM&m=kgYZR7j9jNxZY5G6iGkX8Nf9bEQAwzw58SYTlqkq5XU&s=i6Ph4aPlgeWcqrzXvyfGwzK-2SfBr0VCttizgrkrQ5k&e=" target="_blank">on
 Thursday 11 May</a>). <o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><img border="0" width="544" height="289" style="width:5.6666in;height:3.0104in" id="Picture_x0020_6" src="cid:image006.png@01D43AE3.F8C738E0" alt="Inline images 5"><o:p></o:p></p>
<p class="MsoNormal">I <o:p></o:p></p>
<p class="MsoNormal"><br>
<br clear="all">
<o:p></o:p></p>
</div>
</body>
</html>